Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

357 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
Mizutani M, Kern TS, Lorenzi M. Mizutani M, et al. Among authors: lorenzi m. J Clin Invest. 1996 Jun 15;97(12):2883-90. doi: 10.1172/JCI118746. J Clin Invest. 1996. PMID: 8675702 Free PMC article.
Macular micropseudocysts in early stages of diabetic retinopathy.
Tremolada G, Pierro L, de Benedetto U, Margari S, Gagliardi M, Maestranzi G, Calori G, Lorenzi M, Lattanzio R. Tremolada G, et al. Among authors: lorenzi m. Retina. 2011 Jul-Aug;31(7):1352-8. doi: 10.1097/IAE.0b013e318203c0aa. Retina. 2011. PMID: 21394067
The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.
Dagher Z, Gerhardinger C, Vaz J, Goodridge M, Tecilazich F, Lorenzi M. Dagher Z, et al. Among authors: lorenzi m. Am J Pathol. 2017 Mar;187(3):627-638. doi: 10.1016/j.ajpath.2016.11.007. Epub 2017 Feb 2. Am J Pathol. 2017. PMID: 28162229 Free PMC article.
Defective Myogenic Response of Retinal Vessels Is Associated With Accelerated Onset of Retinopathy in Type 1 Diabetic Individuals.
Tecilazich F, Feke GT, Mazzantini S, Sobrin L, Lorenzi M. Tecilazich F, et al. Among authors: lorenzi m. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1523-9. doi: 10.1167/iovs.15-18356. Invest Ophthalmol Vis Sci. 2016. PMID: 27035625
Retinal vascular caliber as a biomarker for diabetes microvascular complications.
Ikram MK, Cheung CY, Lorenzi M, Klein R, Jones TL, Wong TY; NIH/JDRF Workshop on Retinal Biomarker for Diabetes Group. Ikram MK, et al. Among authors: lorenzi m. Diabetes Care. 2013 Mar;36(3):750-9. doi: 10.2337/dc12-1554. Diabetes Care. 2013. PMID: 23431093 Free PMC article. Review. No abstract available.
Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy.
Lorenzi M, Feke GT, Pitler L, Berisha F, Kolodjaschna J, McMeel JW. Lorenzi M, et al. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6770-5. doi: 10.1167/iovs.10-5785. Epub 2010 Jun 30. Invest Ophthalmol Vis Sci. 2010. PMID: 20592228
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy.
Gerhardinger C, Dagher Z, Sebastiani P, Park YS, Lorenzi M. Gerhardinger C, et al. Among authors: lorenzi m. Diabetes. 2009 Jul;58(7):1659-67. doi: 10.2337/db08-1008. Epub 2009 Apr 28. Diabetes. 2009. PMID: 19401417 Free PMC article.
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
Lorenzi M. Lorenzi M. Exp Diabetes Res. 2007;2007:61038. doi: 10.1155/2007/61038. Exp Diabetes Res. 2007. PMID: 18224243 Free PMC article. Review.
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M. Sun W, et al. Among authors: lorenzi m. Diabetes. 2006 Oct;55(10):2757-62. doi: 10.2337/db06-0138. Diabetes. 2006. PMID: 17003340
Mechanisms and strategies for prevention in diabetic retinopathy.
Lorenzi M. Lorenzi M. Curr Diab Rep. 2006 Apr;6(2):102-7. doi: 10.1007/s11892-006-0019-6. Curr Diab Rep. 2006. PMID: 16542619 Review.
357 results
Jump to page